ZelosDx, Inc.
Blood test diagnostic platform that captures and quantifies debris-laden immune cells (phagocytes) from finger-prick samples to detect neurologic biomarkers indicating brain disease or injury onset
- Sector
- Medtech
- Total capital
- $256K
- Federal grants
- $256K
- 1 award · 2021
- Rank in peer group#33 of 68
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Federal grantNSF · Phase I · SBIR Phase I: Phagocytic Cells in Peripheral Blood as a Novel Diagnostic Tool for Brain Health$256K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 68 peers
Line = medianMedtech · Instrument
- Federal grants#33 · top 49%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 8- PendingDetection Of Debris In Recirculating PhagocytesUSPTOApplication 18379431
- PendingDetection Of Neural-derived Debris In Recirculating PhagocytesUSPTOApplication 17719177
- PendingDetection Of Neural-derived Debris In Recirculating PhagocytesUSPTOApplication 17228416
Show all 8 patent records
- Detection Of Debris In Recirculating PhagocytesFeb 1, 2024 · Application 18379431Pending
- Detection Of Neural-derived Debris In Recirculating PhagocytesJul 28, 2022 · Application 17719177Pending
- Detection Of Neural-derived Debris In Recirculating PhagocytesJul 28, 2022 · Application 17228416Pending
- Detection Of Debris In Recirculating PhagocytesJul 28, 2022 · Application 17719243Pending
- Detection Of Debris In Recirculating PhagocytesApplication 62845670Pending
- Detection Of Debris In Recirculating PhagocytesApplication PCTUS2022024482Pending
- Detection Of Neural-derived Debris In Recirculating PhagocytesApplication PCTUS2022024457Pending
- Detection Of Debris In Recirculating PhagocytesApplication 16872064Pending
Related companies, and why
- IVOS MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
- BIOSENS8, INC.Similar federal contract value in Medtech · null in contracts
- Compact Medical Solutions LLCSimilar federal contract value in Medtech · null in contracts
- HYPERSOUND MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
- COLLAMEDIX INC.Similar federal contract value in Medtech · null in contracts
- OPTAVE DIAGNOSTICS LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .